Tong Zhou

Dr. Tong Zhou


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2013 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
GZGuangjun Zhang
Guangjun Zhang
HZHe Zhou
He Zhou
HXHuaxu Xiao
Huaxu Xiao
ZLZuoliang Liu
Zuoliang Liu
HTHongpeng Tian
Hongpeng Tian
TZTong Zhou
Tong Zhou

20 February 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
GZGuang-Jun Zhang
Guang-Jun Zhang
HZHe Zhou
He Zhou
HXHua-Xu Xiao
Hua-Xu Xiao
YLYu Li
Yu Li
TZTong Zhou
Tong Zhou
Background: MicroRNAs(miRNAs) are small non-coding RNAs that participate in a variety of biologic processes, and dysregulation of miRNA is always associated with cancer development and progression. Aberrant expression of miR-378 has been found in some types of cancer. However, effects and potential mechanisms of miR-378 in colorectal cancer (CRC) have not been explored. Methods: Quantitative RT-PCR was performed to evaluate miR-378 levels in CRC cell lines and 84 pairs of CRC cancer and normal adjacent mucosa. Kaplan–Meier and Cox proportional regression analyses were utilized to determine the association of miR-378 expression with survival of patients. MTT and invasion assays were used to determine the role of miR-378 in regulation of CRC cancer cell growth and invasion, respectively. Tumor growth was assessed by subcutaneous inoculation of cells into BALB/c nude mice. Luciferase assay was performed to assess miR-378 binding to vimentin gene. Results: In this study, we confirmed that miR-378 significantly down-regulated in CRC cancer tissues and cell lines. Moreover, patients with low miR-378 expression had significantly poorer overall survival, and miR-378 expression was an independent prognostic factor in CRC. Over-expression of miR-378 inhibited SW620 cell growth and invasion, and resulted in down-regulation of vimentin expression. However, miR-378 knock-down promoted these processes and enhanced the expression of vimentin. In addition, we further identified vimentin as the functional downstream target of miR-378 by directly targeting the 3′-UTR of vimentin. Conclusions: In conclusion, miR-378 may function as a tumor suppressor and plays an important role in inhibiting tumor growth and invasion. Our present results implicate the potential effects of miR-378 on prognosis and treatment of CRC cancer.

14 November 2012 in Oncology Letters
Verified
Journal Article
Open access
PDF file
GZGuang-Jun Zhang
Guang-Jun Zhang
TZTong Zhou
Tong Zhou
HTHong-Peng Tian
Hong-Peng Tian
ZLZuo-Liang Liu
Zuo-Liang Liu
SXShu-Sen Xia
Shu-Sen Xia
Zinc finger E-box binding homeobox 1 (ZEB1) has been shown to promote invasion and metastasis in several types of human cancer and to have a prognostic role in certain cancers. However, the clinical significance of ZEB1 in colorectal cancer (CRC) has not been sufficiently investigated. This study aimed to address this issue. In this study, we compared the expression of ZEB1 between CRC tissues and normal adjacent mucosa using quantitative real-time RT-PCR. The association of ZEB1 expression with clinicopathological characteristics was analyzed by appropriate statistical analyses. Kaplan-Meier analysis and Cox proportional hazards regression models were used to investigate the association of ZEB1 expression with survival of patients. The results showed that the relative expression levels of ZEB1 were significantly higher in CRC tissues compared to the normal adjacent mucosa and higher expression of ZEB1 correlated with liver metastasis. Kaplan-Meier analysis indicated that patients with high ZEB1 had a poor overall survival. Moreover, the multivariate analysis showed that high expression of ZEB1 was an independent predictor of overall survival. Our data indicate the potential of ZEB1 as a novel prognostic biomarker for CRC.

9 October 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
GZGuang-Jun Zhang
Guang-Jun Zhang
LLLi-Fa Li
Li-Fa Li
GYGuo-Dong Yang
Guo-Dong Yang
SXShu-Sen Xia
Shu-Sen Xia
RWRong Wang
Rong Wang
TZTong Zhou
Tong Zhou
MiR-92a promotes stem cell-like properties by activating Wnt/-catenin signaling in colorectal cancer MiR-92a promotes stem cell-like properties by activating Wnt/β-catenin signaling in colorectal cancer

30 July 2015 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
GZGuang-Jun Zhang
Guang-Jun Zhang
JLJian-Shui Li
Jian-Shui Li
HZHe Zhou
He Zhou
HXHua-Xu Xiao
Hua-Xu Xiao
YLYu Li
Yu Li
TZTong Zhou
Tong Zhou
Growing evidence suggests that microRNAs (miRNAs) play an important role in tumor development, progression and metastasis. Aberrant miR-106b expression has been reported in several cancers. However, the role and underlying mechanism of miR-106 in colorectal cancer (CRC) have not been addressed. Quantitative RT-PCR(qRT-PCR) was performed to evaluate miR-106b levels in CRC cell lines and patient specimens. Cell proliferation was detected using MTT assay, and cell migration and invasion ability were evaluated by wound healing assay and transwell assay. The target gene of miR-106b was determined by qRT-PCR, western blot and luciferase assays. miR-106b was significantly up-regulated in metastatic CRC tissues and cell lines, and high miR-106b expression was associated with lymph node metastasis and advanced clinical stage. In addition, miR-106b overexpression enhances, whereas miR-106b depletion reduces CRC cell migration and invasion. Moreover, we identify DLC1 as a direct target of miR-106b, reveal its expression to be inversely correlated with miR-106b in CRC samples and show that its re-introduction reverses miR-106b-induced CRC cell migration and invasion. Furthermore, survival analyses showed the patients with high mi-106b/low DLC1 had shorter overall survival (OS) and disease-free survival (DFS) rates, and confirmed miR-106b may be an independent prognostic factor for OS and DFS in CRC patients. Our findings indicate that miR-106b promotes CRC cell migration and invasion by targeting DLC1. This miRNA may serve as a potential prognostic biomarker and therapeutic target for CRC.

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
TZTong Zhou
Tong Zhou
XWXiao-Ting Wu
Xiao-Ting Wu
YZYe-Jiang Zhou
Ye-Jiang Zhou
XHXiong Huang
Xiong Huang
WFWei Fan
Wei Fan
YLYue-Chun Li
Yue-Chun Li
AIM: To evaluate the feasibility, safety, and tolerance of early removing gastrointestinal decompression and early oral feeding in the patients undergoing surgery for colorectal carcinoma. METHODS: Three hundred and sixteen patients submitted to operations associated with colorectostomy from January 2004 to September 2005 were randomized to two groups: In experimental group (n